CR20110377A - Protozzo modificado que expresa al menos dos proteinas variables de superficie (vsp), vacuna que lo comprende, procedimientos usos y métodos - Google Patents

Protozzo modificado que expresa al menos dos proteinas variables de superficie (vsp), vacuna que lo comprende, procedimientos usos y métodos

Info

Publication number
CR20110377A
CR20110377A CR20110377A CR20110377A CR20110377A CR 20110377 A CR20110377 A CR 20110377A CR 20110377 A CR20110377 A CR 20110377A CR 20110377 A CR20110377 A CR 20110377A CR 20110377 A CR20110377 A CR 20110377A
Authority
CR
Costa Rica
Prior art keywords
modified
vsp
protozz
vaccine
expressing
Prior art date
Application number
CR20110377A
Other languages
English (en)
Inventor
Hugo Daniel Lujan
Original Assignee
Consejo Nac Invest Cient Tec
Univ Catolica De Cordoba
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consejo Nac Invest Cient Tec, Univ Catolica De Cordoba filed Critical Consejo Nac Invest Cient Tec
Publication of CR20110377A publication Critical patent/CR20110377A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/10—Protozoa; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Protozoo parásitos modificados que comprenden la expresión simultánea en su superficie de al menos dos proteínas variables de superficie (VSP). Los protozoos modificados pueden también expresar en forma simultánea el repertorio completo de proteínas variables de superficie.
CR20110377A 2008-12-02 2011-07-01 Protozzo modificado que expresa al menos dos proteinas variables de superficie (vsp), vacuna que lo comprende, procedimientos usos y métodos CR20110377A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11905808P 2008-12-02 2008-12-02

Publications (1)

Publication Number Publication Date
CR20110377A true CR20110377A (es) 2011-10-20

Family

ID=42233679

Family Applications (1)

Application Number Title Priority Date Filing Date
CR20110377A CR20110377A (es) 2008-12-02 2011-07-01 Protozzo modificado que expresa al menos dos proteinas variables de superficie (vsp), vacuna que lo comprende, procedimientos usos y métodos

Country Status (18)

Country Link
US (1) US9463229B2 (es)
EP (1) EP2364156B1 (es)
JP (3) JP2012510286A (es)
CN (1) CN102281884B (es)
AR (1) AR074458A1 (es)
AU (1) AU2009323734B2 (es)
BR (1) BRPI0917075B1 (es)
CA (1) CA2745470C (es)
CL (2) CL2011001309A1 (es)
CO (1) CO6390115A2 (es)
CR (1) CR20110377A (es)
EC (1) ECSP11011171A (es)
ES (1) ES2667773T3 (es)
MX (2) MX351579B (es)
NZ (2) NZ604943A (es)
PE (2) PE20150889A1 (es)
PT (1) PT2364156T (es)
WO (1) WO2010064204A2 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9457096B2 (en) 2012-07-06 2016-10-04 Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery
EP4566624A1 (en) * 2023-12-04 2025-06-11 VacciMed-Oral GmbH Vaccines against protozoan parasites

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5512288A (en) * 1992-12-04 1996-04-30 University Technologies International, Inc. Giardia vaccine
US5585250A (en) * 1993-08-20 1996-12-17 The United States Of America As Represented By The Department Of Health & Human Services Dampening of an immunodominant epitope of an antigen for use in plant, animal and human compositions and immunotherapies
US6171820B1 (en) * 1995-12-07 2001-01-09 Diversa Corporation Saturation mutagenesis in directed evolution
JP2000083677A (ja) * 1998-09-17 2000-03-28 Bayer Ltd ダニワクチン
GB0000474D0 (en) * 2000-01-10 2000-03-01 Inal Jameel M Receptor

Also Published As

Publication number Publication date
PT2364156T (pt) 2018-04-24
EP2364156A2 (en) 2011-09-14
AU2009323734B2 (en) 2016-06-30
AU2009323734A1 (en) 2010-06-10
EP2364156B1 (en) 2018-01-31
JP2012510286A (ja) 2012-05-10
MX2011005815A (es) 2011-09-30
CN102281884A (zh) 2011-12-14
BRPI0917075B1 (pt) 2019-11-12
PE20150889A1 (es) 2015-06-07
US9463229B2 (en) 2016-10-11
CL2018002834A1 (es) 2019-04-05
CL2011001309A1 (es) 2012-03-16
CA2745470A1 (en) 2010-06-10
BRPI0917075A2 (pt) 2016-08-02
JP6793621B2 (ja) 2020-12-02
WO2010064204A2 (en) 2010-06-10
PE20110942A1 (es) 2011-12-30
NZ593106A (en) 2013-05-31
WO2010064204A3 (en) 2010-12-02
JP2016000045A (ja) 2016-01-07
ECSP11011171A (es) 2011-09-30
AR074458A1 (es) 2011-01-19
NZ604943A (en) 2014-08-29
CA2745470C (en) 2018-09-25
JP2018024700A (ja) 2018-02-15
CN102281884B (zh) 2015-09-30
ES2667773T3 (es) 2018-05-14
MX351579B (es) 2017-10-20
US20120093871A1 (en) 2012-04-19
CO6390115A2 (es) 2012-02-29

Similar Documents

Publication Publication Date Title
EP2615652A4 (en) LIGHT-EMITTING DEVICE, LIGHTING DEVICE AND LENS
EP2162926A4 (en) LUMINOUS DIODES AND MANUFACTURING METHOD THEREFOR
CL2007003661A1 (es) Regiones de cadena pesada variable y liviana variable; acidos nucleicos que las codifican; metodo de produccion; anticuerpos anti-notch3 que las comprenden; y uso de los anticuerpos para tratar enfermedades relacionadas con el receptor notch3.
EP3692091A4 (en) OPTICALLY TRANSPARENT POLYIMIDE
EP3426978A4 (en) INTELLIGENT CANDLE PLATFORM AND SYSTEM
EP2778507A4 (en) WHITE LIGHT SOURCE AND WHITE LIGHT SOURCE SYSTEM THEREWITH
CL2017002756A1 (es) Adhesivos acrílicos en emulsión
EP3176836C0 (en) WHITE LIGHT EMITTING DEVICE, LIGHTING SYSTEM AND DENTAL LIGHTING SYSTEM
CL2008003661A1 (es) Metodo y dispositivo para determinar cuantitativamente las caracteristicas opticas superficiales de un objeto de referencia compuesto por una pluralidad de capas opticamente diferenciables.
EP2569247A4 (en) FLUORESCENT ON CARBONITRIDE BASE AND LIGHT-EMITTING DEVICES THEREWITH
MY191348A (en) Antibodies and derivatives thereof
EP3367889A4 (en) OPTICAL PHYSIOLOGICAL SENSORS AND METHOD
EP2685496A3 (en) Light emitting apparatus
BRPI1007104A2 (pt) dispositivo óptico no campo de iluminação de palco
JP2017502341A5 (es)
EP3392549A4 (en) LIGHT SOURCE SYSTEM AND LIGHTING SYSTEM
EP3564582A4 (en) FLUORESCENT LIGHT SOURCE APPARATUS AND MANUFACTURING METHOD THEREOF
PL3208514T3 (pl) Żarówka wykorzystująca włókno LED
EP2796775A4 (en) OPTICAL PLATE FOR ILLUMINATION AND LIGHTING DEVICE THEREFOR
EP4046586A4 (en) Light emitting device and light emitting system
EP2827393A4 (en) LIGHT-EMITTING DEVICE AND LIGHTING DEVICE
CR20110377A (es) Protozzo modificado que expresa al menos dos proteinas variables de superficie (vsp), vacuna que lo comprende, procedimientos usos y métodos
EP3555680A4 (en) SELECTIVE WAVELENGTH TRANSFER OF OPTICAL ENERGY
EA201300514A1 (ru) Разлагаемые волокна
CL2018001208A1 (es) Adhesivos sensibles a estímulos